SCHEMBL8944148

SCHEMBL8944148

OC(CN1CCN(c2cccc(Cl)c2)CC1)c1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 2/20 0.79
KMT2A Q03164 4/20 0.77
MEN1 O00255 3/20 0.77
TSHR P16473 2/20 0.77
CYP1A2 P05177 1/20 0.77
CYP3A4 P08684 1/20 0.77
CYP2D6 P10635 1/20 0.77
MAPT P10636 1/20 0.77
ALOX15 P16050 1/20 0.77
CYP2C19 P33261 1/20 0.77
HIF1A Q16665 1/20 0.77
LMNA P02545 2/20 0.75
NPSR1 Q6W5P4 2/20 0.75
GMNN O75496 1/20 0.75
BLM P54132 1/20 0.75
PMP22 Q01453 1/20 0.75
HTR1A P08908 1/20 0.64
HTR7 P34969 1/20 0.64
RECQL P46063 2/20 0.58
SIGMAR1 Q99720 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27959848 0.88 IGF1R (1.00) IGF1RKMT2AMEN1TSHRCYP1A2
Brl-15,572 SCHEMBL7741355 0.87 MEN1 (1.00) IGF1RKMT2AMEN1TSHRCYP1A2
Brl-15,572 SCHEMBL17978413 0.86 MEN1 (1.00) IGF1RKMT2AMEN1TSHRCYP1A2
SCHEMBL1460309 0.85 KMT2A (1.00) IGF1RKMT2AMEN1MAPTHTR1A
SCHEMBL25305786 0.82 IGF1R (0.60) IGF1RKMT2AMEN1TSHRCYP1A2
SCHEMBL10726186 0.81 IGF1R (0.67) IGF1RKMT2AMEN1TSHRCYP1A2
SCHEMBL10730411 0.81 IGF1R (0.67) IGF1RKMT2AMEN1TSHRCYP1A2
SCHEMBL11402774 0.79 ADRA1D (0.69) IGF1RKMT2AMEN1TSHRCYP1A2
SCHEMBL10746494 0.79 GAA (0.82) IGF1RKMT2AMEN1KDM4E
SCHEMBL2796836 0.79 GAA (0.82) IGF1RKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5541326-A PHARMACEUTICAL COMPOSITION USED TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS JOHN WYETH & BROTHER, LIMITED (GB) 1996-07-30 US disclosed
US-5420278-A ω-(4-aryl or heteroarylpiperazine-1-yl)-2-aryl or aralkyl-propanoic or butanoic acids JOHN WYETH & BROTHER, LIMITED (GB) 1995-05-30 US disclosed
US-5382583-A Hydroxytryptamine antagonists JOHN WYETH & BROTHER, LIMITED (GB) 1995-01-17 US disclosed
US-5340812-A Antiserotonin. anxiolytic agents JOHN WYETH & BROTHER, LIMITED (GB) 1994-08-23 US disclosed
EP-0395312-A2 Piperazine derivatives JOHN WYETH & BROTHER LIMITED (GB) 1990-10-31 EP disclosed